Status:
ACTIVE_NOT_RECRUITING
Dexmedetomidine and Sufentanil Effect in PCA on Pediatric Patients Undergoing Scoliosis Surgery
Lead Sponsor:
Peking Union Medical College Hospital
Conditions:
Dexmedetomidine
Eligibility:
All Genders
1-14 years
Phase:
NA
Brief Summary
The primary purpose of this three-arm single center, randomized, subject and assessor blind, controlled clinical study is to evaluate the effect of dexmedetomidine on patient-controlled intravenous an...
Detailed Description
The study is a single center, randomized, subject and assessor blinded, controlled clinical study. Children who meet the inclusion/exclusion criteria will be evaluated. The patients will use a postop...
Eligibility Criteria
Inclusion
- Aged 1-14 years scheduled to receive scoliosis orthopedics under general anesthesia;
- Weight is ±15% of standard weight (standard weight (kg) = height (cm) -100);
- Informed consent signed.
Exclusion
- Allergy to dexmedetomidine;
- Obvious abnormalities of heart, lung, liver, renal function and endocrine function;
- Patients who can not cooperate with this trial.
Key Trial Info
Start Date :
September 23 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT05249153
Start Date
September 23 2020
End Date
December 31 2025
Last Update
November 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China, 100730